Trials / Completed
CompletedNCT02995265
Exoskeleton for Post-Stroke Recovery of Ambulation
Use of a Robotic Exoskeleton to Promote Walking Recovery After Stroke - Phase 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effect of using a robotic exoskeleton to allow walking practice after stroke, compared to usual physiotherapy care, on recovery of walking ability and secondary outcomes.
Detailed description
Participants admitted to inpatient stroke rehabilitation for physiotherapy services will be randomly assigned to either the Exoskeleton Program or Usual Care Program. Individuals in the Exoskeleton Program will have their usual physiotherapy sessions replaced with the exoskeleton intervention. The exoskeleton will allow standing and walking from the first sessions in rehabilitation, as the exoskeleton provides the physical support to allow walking in full weight-bearing without being limited by therapist fatigue and lifting requirements. Individuals in the Usual Care Program will receive standard physiotherapy care, which is individualized and hands-on with their therapist to regain walking, mobility, and independent function. Both groups will be conducted 3-5 days a week, 30-60 minutes per session until discharge (to a maximum of 8 weeks). Participants will be assessed at baseline, discharge, and 6-months after starting rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exoskeleton Program | Subjects will wear the exoskeleton device at each physiotherapy session to work on improving mobility and walking ability. |
| OTHER | Usual Care Program | Subjects will receive hands-on physiotherapy to improve their mobility and walking ability. Physiotherapy session will be tailored to subject individually by their therapist. |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2020-02-08
- Completion
- 2020-06-30
- First posted
- 2016-12-16
- Last updated
- 2020-08-31
Locations
3 sites across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02995265. Inclusion in this directory is not an endorsement.